Author Maass, Fabian
-
2019 | Journal Article
Cerebrospinal fluid biomarker for Parkinson's disease: An overview
Maass, F.; Schulz, I.; Lingor, P.; Mollenhauer, B. & Bähr, M. (2019)
Molecular and Cellular Neuroscience, 97 pp. 60-66. DOI: https://doi.org/10.1016/j.mcn.2018.12.005
Details DOI
-
2019 | Journal Article |
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Zella, M.; Metzdorf, J.; Ostendorf, F.; Maass, F.; Muhlack, S.; Gold, R. & Haghikia, A. et al. (2019)
Cells, 8(2) pp. 105. DOI: https://doi.org/10.3390/cells8020105
Details DOI
-
2020 | Journal Article
Human cerebrospinal fluid data for use as spectral library, for biomarker research
Schilde, L. M.; Steinbach, S.; Serschnitzki, B.; Maass, F.; Bähr, M.; Lingor, P. & Marcus, K. et al. (2020)
Data in Brief, 32 pp. 106048. DOI: https://doi.org/10.1016/j.dib.2020.106048
Details DOI
-
2021 | Journal Article
Validation of Plasma Neurofilament Light Chain as a Marker for α‐Synucleinopathies
Schmitz, M.; Canaslan, S.; Villar‐Piqué, A.; Gmitterová, K.; Varges, D.; Lingor, P. & Llorens, F. et al. (2021)
Movement Disorders, art. mds.28724. DOI: https://doi.org/10.1002/mds.28724
Details DOI
-
2021 | Journal Article
MicroRNAs from extracellular vesicles as a signature for Parkinson's disease
Caldi Gomes, L.; Roser, A.; Jain, G.; Pena Centeno, T.; Maass, F.; Schilde, L. & May, C. et al. (2021)
Clinical and Translational Medicine, 11(4). DOI: https://doi.org/10.1002/ctm2.357
Details DOI
-
2021 | Journal Article | Research Paper |
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
Canaslan, S.; Schmitz, M.; Villar-Piqué, A.; Maass, F.; Gmitterová, K.; Varges, D. & Lingor, P. et al. (2021)
Frontiers in Aging Neuroscience, 13. DOI: https://doi.org/10.3389/fnagi.2021.717930
Details DOI
-
2022 | Journal Article
Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease
Schmitz, M.; Canaslan, S.; Espinosa, J. C.; Fernández-Borges, N.; Villar-Piqué, A.; Llorens, F. & Varges, D. et al. (2022)
Molecular Neurobiology,. DOI: https://doi.org/10.1007/s12035-022-02891-7
Details DOI
-
2022 | Journal Article | Research Paper
Baseline Cerebrospinal Fluid alpha-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline
Emdina, A.; Hermann, P.; Varges, D.; Nuhn, S.; Goebel, S.; Bunck, T. & Maass, F. et al. (2022)
Diagnostics, 12(5) art. 1259. DOI: https://doi.org/10.3390/diagnostics12031259
Details DOI
-
2022 | Journal Article
Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease
Caldi Gomes, L.; Galhoz, A.; Jain, G.; Roser, A.; Maass, F.; Carboni, E. & Barski, E. et al. (2022)
Clinical and Translational Medicine, 12(1). DOI: https://doi.org/10.1002/ctm2.692
Details DOI
-
2022 | Journal Article | Research Paper |
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
Emdina, A.; Hermann, P.; Varges, D.; Nuhn, S.; Goebel, S.; Bunck, T. & Maass, F. et al. (2022)
Diagnostics, 12(5) pp. 1259. DOI: https://doi.org/10.3390/diagnostics12051259
Details DOI
-
2022 | Journal Article | Research Paper
The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
Garg, P.; Maass, F.; Sundaram, S. M.; Mollenhauer, B.; Mahajani, S.; van Riesen, C. & Kügler, S. et al. (2022)
Molecular and Cellular Neuroscience, 121 art. 103746. DOI: https://doi.org/10.1016/j.mcn.2022.103746
Details DOI PMID PMC
-
2023 | Journal Article
Detection of Prion Protein Seeding Activity in Tear Fluids
Schmitz, M.; Silva Correia, S.; Hermann, P.; Maass, F.; Goebel, S.; Bunck, T. & Correia, A. et al. (2023)
New England Journal of Medicine, 388(19) pp. 1816-1817. DOI: https://doi.org/10.1056/NEJMc2214647
Details DOI
-
2023 | Journal Article |
Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
Müller, S. J.; Khadhraoui, E.; Hansen, N.; Jamous, A.; Langer, P.; Wiltfang, J. & Riedel, C. H. et al. (2023)
BMC Neurology, 23(1) art. 114. DOI: https://doi.org/10.1186/s12883-023-03151-4
Details DOI
-
2023 | Journal Article |
Spinocerebellar Ataxia Type 35 Caused by a New TGM6 Variant: Video Documentation of a German Family
Maass, F.; Jamous, A.; Biskup, S.; Eisenberg, H.; D'Hedouville, Z.; Bähr, M. & van Riesen, C. (2023)
Movement Disorders Clinical Practice, 10(6) art. mdc3.13717. DOI: https://doi.org/10.1002/mdc3.13717
Details DOI
-
2024 | Journal Article
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
Carmona, A.; Carboni, E.; Gomes, L. C.; Roudeau, S.; Maass, F.; Lenz, C. & Ortega, R. et al. (2024)
Journal of Neurochemistry, 168(2) pp. 128-141. DOI: https://doi.org/10.1111/jnc.16040
Details DOI
-
2024 | Journal Article
Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease
Tatenhorst, L.; Maass, F.; Paul, H.; Dambeck, V.; Bähr, M.; Dono, R. & Lingor, P. (2024)
Scientific Reports, 14(1). DOI: https://doi.org/10.1038/s41598-024-54800-8
Details DOI